Tenaya Therapeutics (NASDAQ: TNYA)
$1.13
(-2.6%)
-$0.03
Price as of August 22, 2025, 4:00 p.m. ET
Tenaya Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Tenaya Therapeutics Company Info
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in August 2016 and is headquartered in South San Francisco, CA.
News & Analysis
Featured Article
Tenaya (TNYA) Q2 Loss Narrows 59%
Motley Fool Markets Team | Aug 7, 2025
Featured Article
Why This Nasdaq Stock Caught Fire This Week
A wave of bargain buying benefited the gene therapy company's shares this week.
George Budwell | Apr 20, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.